Skip to main navigation

Overview
News & Events
Financial Information
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Governance
IR Resources

Media News

Street cheering Immuneering’s phase IIa pancreatic data

Source

BioWorld

MM-1-104 and Chemo Combination Elicit Responses in First-Line Pancreatic Cancer

Source

OncLive

AACR roundup: Immuneering accelerates RAS drug

Source

EndPoints News

Immuneering reveals positive data from tumour treatment trial

Source

PharmaTimes

Universal picture's clearer in human RAS inhibition as Phase 1 data from Immuneering screened at AACR

Source

BioWorld

Tackling Uncertainty In Drug R&D

Source

Life Science Leader

Disease Cancelling Technology Emulates Sound Cancelling Technology to Mute Cancer

Source

Genetic Engineering & Biotechnology News

Print Page

Email Alerts

Email Page

RSS Feeds

Site - Footer Menu

ABOUT
PLATFORM
PIPELINE
NEWSROOM
PUBLICATIONS
CONTACT

Connect with us on social media.

Linkedin Twitter

© Immuneering Corporation 2024

Site - Footer Bottom

Terms of Use
Privacy Policy